Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
GlobalData on MSN6 个月
Abbott and Medtronic partner to integrate CGM system with insulin devices
The platform, which includes the new form factor CGM and the Simplera Sync sensor, is designed for integration with Medtronic ...
Healio19 天
Although superior to other insulin therapies, hybrid closed-loop systems differ in efficacy
MiniMed 670G and MiniMed 780G (Medtronic); t:slim X2 with Control-IQ technology (Tandem Diabetes Care); CamAPS Fx (CamDiab Ltd.); Diabeloop Generation 1 (DBLG‐1; Diabeloop) and Diabeloop for ...
thecardiologyadvisor.com3 天
Hybrid Closed Loop Technology Outperforms Standard Insulin in T1D
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.